Evidence map›Paper›PMID 32425328›Full record

ReviewThe Canadian journal of cardiology2020

Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective.

Marouane Boukhris, Ali Hillani, Francesco Moroni, Mohamed Salah Annabi, Faouzi Addad, Marcelo Harada Ribeiro, Samer Mansour, Xiaohui Zhao, Luiz Fernando Ybarra, Antonio Abbate and 2 more

Open access · bronzeAbstract readReview
In one paragraph

Review in The Canadian journal of cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 6 pooled it
4.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 6 syntheses or guidelines pooled it, 181 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Hyperparameter optimization for cardiovascular disease data-driven prognostic system.Visual computing for industry, biomedicine, and art · 2023
    Article
  19. Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 5 countries.

Marouane BoukhrisDivision of Cardiology, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
Ali HillaniDivision of Cardiology, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
Francesco MoroniUniversità Vita-Salute San Raffaele, Milan, Italy.
Mohamed Salah AnnabiCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université de Laval, Québec, Québec, Canada.
Faouzi AddadDivision of Cardiology, Abderrahmen Mami Hospital, Ariana, Tunisia.
Marcelo Harada RibeiroSOS Cardio Hospital, Florianópolis, Santa Catarina, Brazil.
Samer MansourDivision of Cardiology, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
Xiaohui ZhaoInstitute of Cardiovascular Research, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Luiz Fernando YbarraLondon Health Sciences Centre, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Antonio AbbateDivision of Cardiology, VCU Pauley Heart Center and Wright Center for Clinical and Translationa Research, Virginia Commonwealth University, Richmond, Virginia, USA.
Luz Maria VilcaDepartment of Obstetrics and Gynecology, Buzzi Hospital-ASST Fatebenefratelli Sacco, University of Milan, Milan, Italy.
Lorenzo AzzaliniThe Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: lorenzo.azzalini@mountsinai.org.
Centre Hospitalier de l’Université de Montréal · CAAbderrahmane Mami Hospital · TNArmy Medical University · CNASST Fatebenefratelli Sacco · ITCardiovascular Institute of the South · USInstitut Universitaire de Cardiologie et de Pneumologie de Québec · CALondon Health Sciences Centre · CAVirginia Commonwealth University · USVita-Salute San Raffaele University · IT

Funding

Research Supplement to Promote Diversity in Health Related ResearchUL1TR002649 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI MOELLER, FREDERICK GERARD · 2018 to 2022
$19.1M
NCATS NIH HHS UL1 TR002649
6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), represents the pandemic of the century, with approximately 3.5 million cases and 250,000 deaths worldwide as of May 2020. Although respiratory symptoms usually dominate the clinical presentation, COVID-19 is now known to also have potentially serious cardiovascular consequences, including myocardial injury, myocarditis, acute coronary syndromes, pulmonary embolism, stroke, arrhythmias, heart failure, and cardiogenic shock. The cardiac manifestations of COVID-19 might be related to the adrenergic drive, systemic inflammatory milieu and cytokine-release syndrome caused by SARS-CoV-2, direct viral infection of myocardial and endothelial cells, hypoxia due to respiratory failure, electrolytic imbalances, fluid overload, and side effects of certain COVID-19 medications. COVID-19 has profoundly reshaped usual care of both ambulatory and acute cardiac patients, by leading to the cancellation of elective procedures and by reducing the efficiency of existing pathways of urgent care, respectively. Decreased use of health care services for acute conditions by non-COVID-19 patients has also been reported and attributed to concerns about acquiring in-hospital infection. Innovative approaches that leverage modern technologies to tackle the COVID-19 pandemic have been introduced, which include telemedicine, dissemination of educational material over social media, smartphone apps for case tracking, and artificial intelligence for pandemic modelling, among others. This article provides a comprehensive overview of the pathophysiology and cardiovascular implications of COVID-19, its impact on existing pathways of care, the role of modern technologies to tackle the pandemic, and a proposal of novel management algorithms for the most common acute cardiac conditions.

Indexed as

Cause of DeathCardiovascular DiseasesComorbidityCoronavirus InfectionsCOVID-19FemaleGlobal HealthHospital MortalityHumansMalePandemicsPneumonia, ViralPrevalenceRisk AssessmentSevere Acute Respiratory SyndromeSurvival Analysis

Identifiers

PMID32425328
PMCPMC7229739
OpenAlexW3024218484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.